Xsira Pharmaceuticals is developing therapeutics targeting G protein-coupled receptors (GPCRs)
History:
Xsira Pharmaceuticals changed their name from Norak Biosciences in early 2005, reflecting their refocus from a platform technology company to a pharmaceutical company.
